skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:057889/0489   Pages: 7
Recorded: 10/22/2021
Conveyance: PATENT SECURITY AGREEMENT
Total properties: 7
1
Patent #:
Issue Dt:
07/06/2010
Application #:
10819620
Filing Dt:
04/07/2004
Publication #:
Pub Dt:
11/18/2004
Title:
ONCE DAILY FORMULATIONS OF TETRACYCLINES
2
Patent #:
Issue Dt:
06/26/2012
Application #:
12155676
Filing Dt:
06/06/2008
Publication #:
Pub Dt:
01/08/2009
Title:
ONCE DAILY FORMULATIONS OF TETRACYCLINES
3
Patent #:
Issue Dt:
03/12/2013
Application #:
12926932
Filing Dt:
12/17/2010
Publication #:
Pub Dt:
12/01/2011
Title:
Once daily formulations of tetracyclines
4
Patent #:
Issue Dt:
06/25/2013
Application #:
12926933
Filing Dt:
12/17/2010
Publication #:
Pub Dt:
12/29/2011
Title:
Once daily formulations of tetracyclines
5
Patent #:
Issue Dt:
03/12/2013
Application #:
12926934
Filing Dt:
12/17/2010
Publication #:
Pub Dt:
11/24/2011
Title:
Once daily formulations of tetracyclines
6
Patent #:
Issue Dt:
04/29/2014
Application #:
13920538
Filing Dt:
06/18/2013
Publication #:
Pub Dt:
03/13/2014
Title:
ONCE DAILY FORMULATIONS OF TETRACYCLINES
7
Patent #:
NONE
Issue Dt:
Application #:
17185217
Filing Dt:
02/25/2021
Publication #:
Pub Dt:
01/20/2022
Title:
Once Daily Formulations Of Tetracyclines
Assignor
1
Exec Dt:
10/22/2021
Assignee
1
595 BAY STREET
CPS-5TH FLOOR
TORONTO, ONTARIO, CANADA M5G 2C2
Correspondence name and address
THEODORE BATIS
WEIL, GOTSHAL & MANGES LLP
767 FIFTH AVENUE
NEW YORK, NY 10153

Search Results as of: 06/01/2024 05:34 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT